Studies on Tumors of the Thyroid

• Status: Recruiting
• Trial end date: 2040-12-31
• Target enrollment: 99999
• Participant gender: All

Summary

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.

The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Treatments: Fluorodeoxyglucose F18

Criteria

• INCLUSION CRITERIA:

Adults and children with known or suspected thyroid neoplasm will be considered for participation.

1. Patients with thyroid nodules requiring evaluation and possible biopsy

2. Patients with recent diagnosis of thyroid cancer requiring consultation and counseling about therapeutic options

3. Patients with established thyroid cancer requiring specialized studies such as (131)I dosimetry

4. Enrollment of high risk, non-iodine avid, inoperable thyroid cancer for standard treatment of screening for eligibility for other specific thyroid cancer protocols.

EXCLUSION CRITERIA:

1. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma.